Covered recipient · General Payments record
ELIZABETH KATHLEEN BOSWELL
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$1,723.83
- Reported across 85 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.99 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $159.33 | 4 |
| Novo Nordisk AS | $49.61 | 3 |
| SHIELD THERAPEUTICS INC | $46.74 | 2 |
| Exeltis, USA Inc. | $28.64 | 2 |
| Sumitomo Pharma America, Inc. | $21.64 | 1 |
| Evofem Biosciences, Inc. | $21.28 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.64 | 1 |
| Hologic Sales and Service, LLC | $13.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.35 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533846 | CMS |
| Amgen Inc. | $12.95 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533844 | CMS |
| Amgen Inc. | $119.78 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533850 | CMS |
| Amgen Inc. | $11.25 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533848 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.64 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086175206 | CMS |
| Evofem Biosciences, Inc. | $21.28 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091273886 | CMS |
| Exeltis, USA Inc. | $13.91 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149987860 | CMS |
| Exeltis, USA Inc. | $14.73 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149987864 | CMS |
| Hologic Sales and Service, LLC | $13.11 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084870063 | CMS |
| Novo Nordisk Inc | $13.95 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096733002 | CMS |
| Novo Nordisk Inc | $14.75 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569548 | CMS |
| Novo Nordisk Inc | $20.91 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096608356 | CMS |
| SHIELD THERAPEUTICS INC | $23.53 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150145768 | CMS |
| SHIELD THERAPEUTICS INC | $23.21 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150154136 | CMS |
| Sumitomo Pharma America, Inc. | $21.64 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148830219 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.